Dakota Wealth Management Makes New Investment in Hims & Hers Health, Inc. (NYSE:HIMS)

Dakota Wealth Management bought a new stake in Hims & Hers Health, Inc. (NYSE:HIMS) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 13,285 shares of the company’s stock, valued at approximately $245,000.

Other hedge funds have also modified their holdings of the company. International Assets Investment Management LLC purchased a new stake in Hims & Hers Health during the 3rd quarter worth $6,790,000. Lake Street Private Wealth LLC increased its position in shares of Hims & Hers Health by 80.3% during the third quarter. Lake Street Private Wealth LLC now owns 103,447 shares of the company’s stock worth $1,905,000 after acquiring an additional 46,076 shares during the last quarter. Venture Visionary Partners LLC purchased a new stake in shares of Hims & Hers Health during the third quarter worth about $238,000. Heritage Wealth Management Inc. CA acquired a new position in shares of Hims & Hers Health in the third quarter worth about $297,000. Finally, Means Investment CO. Inc. purchased a new position in Hims & Hers Health in the third quarter valued at about $747,000. 63.52% of the stock is currently owned by hedge funds and other institutional investors.

Hims & Hers Health Stock Performance

Shares of HIMS opened at $23.10 on Tuesday. The firm has a fifty day moving average of $17.73 and a 200-day moving average of $17.94. The company has a market cap of $4.96 billion, a price-to-earnings ratio of 288.79 and a beta of 1.06. Hims & Hers Health, Inc. has a 1 year low of $5.65 and a 1 year high of $25.74.

Hims & Hers Health (NYSE:HIMS) last posted its earnings results on Monday, August 5th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.04 by $0.02. The firm had revenue of $315.65 million during the quarter, compared to analysts’ expectations of $302.43 million. Hims & Hers Health had a net margin of 1.70% and a return on equity of 5.25%. Hims & Hers Health’s quarterly revenue was up 51.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.03) EPS. Analysts predict that Hims & Hers Health, Inc. will post 0.22 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Needham & Company LLC assumed coverage on Hims & Hers Health in a research report on Thursday, August 22nd. They issued a “buy” rating and a $24.00 target price on the stock. Bank of America upped their price target on shares of Hims & Hers Health from $23.00 to $25.00 and gave the company a “buy” rating in a report on Monday, October 21st. Truist Financial raised their price objective on shares of Hims & Hers Health from $13.00 to $23.00 and gave the stock a “hold” rating in a report on Thursday, July 18th. Deutsche Bank Aktiengesellschaft upped their target price on shares of Hims & Hers Health from $16.00 to $23.00 and gave the company a “hold” rating in a research note on Wednesday, August 7th. Finally, TD Cowen lifted their price target on Hims & Hers Health from $15.00 to $25.00 and gave the stock a “buy” rating in a research note on Thursday, July 11th. Eight analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $20.21.

Insider Activity at Hims & Hers Health

In other news, insider Michael Chi sold 7,500 shares of the stock in a transaction on Monday, October 21st. The stock was sold at an average price of $22.20, for a total value of $166,500.00. Following the completion of the transaction, the insider now owns 193,980 shares of the company’s stock, valued at approximately $4,306,356. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, CEO Andrew Dudum sold 188,888 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $14.56, for a total transaction of $2,750,209.28. Following the sale, the chief executive officer now owns 33,502 shares of the company’s stock, valued at $487,789.12. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Michael Chi sold 7,500 shares of the company’s stock in a transaction that occurred on Monday, October 21st. The stock was sold at an average price of $22.20, for a total value of $166,500.00. Following the completion of the sale, the insider now owns 193,980 shares of the company’s stock, valued at $4,306,356. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 841,076 shares of company stock worth $14,759,219 in the last three months. 17.71% of the stock is owned by company insiders.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.